Relationship of adiponectin and resistin levels in umbilical serum, maternal serum and placenta with neonatal birth weight

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 50, Issue 5, 2010, Pages 432-438

  Wang, Jing ^a   Shang, Li Xin ^a   Dong, Xing ^a   Wang, Xin ^a   Wu, Nan ^a   Wang, Shu He ^a   Zhang, Fang ^a   Xu, Li Ming ^a   Xiao, Ying ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Adiponectin; Birth weight; Fetal growth restriction; Fetal macrosomia; Resistin

Indexed keywords

ADIPONECTIN; RESISTIN;

ARTICLE; BIRTH WEIGHT; BODY MASS; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INTRAUTERINE GROWTH RETARDATION; MACROSOMIA; MAJOR CLINICAL STUDY; MALE; MATERNAL SERUM; NEWBORN; PLACENTA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; WEIGHT CONTROL;

ADIPONECTIN; ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; FETAL MACROSOMIA; HUMANS; INFANT, NEWBORN; PLACENTA; PREGNANCY; RESISTIN; STATISTICS, NONPARAMETRIC;

EID: 78650203255     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2010.01184.x     Document Type: Article

References (28)

1. Langley-Evans SC, Gardner DS, Welham SJ. Intrauterine programming of cardiovascular disease by maternal nutritional status. Nutrition 1998;14(1):39-47.
2. Skalkidou A, Petridou E, Papathoma E, Salvanos H, Chrousos G, Trichopoulos D. Birth size and neonatal levels of major components of the IGF system: implications for later risk of cancer. J Pediatr Endocrinol Metab 2002;15(9):1479-1486.
3. McMillen IC, MacLaughlin SM, Muhlhausler BS, Gentili S, Duffield JL, Morrison JL. Developmental origins of adult health and disease: the role of periconceptional and fetal nutrition. Basic Clin Pharmacol Toxicol 2008;102(2):82-89.
4. Silveira PP, Portella AK, Goldani MZ, Barbieri MA. Developmental origins of health and disease. J Pediatr 2007;83(6):494-504.
5. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005;6(1):13-21.
6. Gil-Campos M, Canete R, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004;23(5):963-974.
7. Sivan E, Mazaki-Tovi S, Pariente C et al. Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab 2003;88(12):5656-5660.
8. Kotani Y, Yokota I, Kitamura S, Matsuda J, Naito E, Kuroda Y. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight. Clin Endocrinol 2004;61(4):418-423.
9. Kajantie E, Hytinantti T, Hovi P, Anderson S. Cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. J Clin Endocrinol Metab 2004;89(8):4031-4036.
10. Corbetta S, Bulfamante G, Cortelazzi D et al. Adiponectin expression in human fetal tissues during mid-and late gestation. J Clin Endocrinol Metab 2005;90(4):2397-2402.
11. Caminos JE, Nogueiras R, Gallego R et al. Expression and regulation of adiponectin and receptor in human and rat placenta. J Clin Endocrinol Metab 2005;90(7):4276-4286.
12. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001;409(6818):307-l2.
13. Yura S, Sagawa N, Itoh H et al. Resistin is expressed in the human placenta. J Clin Endocrinol Metab 2003;88(3):1394-1397.
14. Chen D, Dong M, Fang Q, He J, Wang Z, Yang X. Alterations of serum resistin in normal pregnancy and preeclampsia. Clin Sci 2005;108(1):81-84.
15. Yue J. Gynecology and Obstetrics[M]. Bei Jing: People Public Health Press, 2004. 130-137.
16. Winer JC, Zern TL, Taksali SE et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 2006;91(11):4415-4423.
17. Maeda K. Role of adiponectin and adipocyte fatty acid binding protein in the metabolic syndrome. Diabetes Res Clin Pract 2007;77(Suppl 1): S17-S22.
18. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86(5):1930-1935.
19. Mazaki-Tovi S, Kanety H, Pariente C et al. Cord blood adiponectin in large-for-gestational age newborns. Am J Obstet Gynecol. 2005;193(3 Pt 2):1238-1242.
20. Chen J, Tan B, Karteris E et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006;49(6):1292-1302.
21. Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8(11):1288-1295.
22. Yamauchi T, Kamon J, Waki H et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor r deficiency and PPAPr agonist improve insulin resistance. J Biol Chem 2001;276(44):41245-41254.
23. Chan TF, Yuan SS, Chen HS et al. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstet Gynecol Scand 2004;83(2):165-169.
24. Youn BS, Yu KY, Park HJ et al. Plasma resistin concentrations measured by ELISA using a newly-developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004;89(1):150-156.
25. Cho YM, Youn BS, Chung SS, Kim KW, Lee HK, Yu KY. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 2004;47(3):1337-1338.
26. Di Simone N, Di Nicuolo F, Sanguinetti M et al. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes. J Endocrinol 2006;189(3):691-699.
27. Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276(14):11252-11256.
28. Rajala MW, Lin Y, Ranalletta M et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 2002;16(8):1920-1930.